1erq: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1erq.png|left|200px]] | [[Image:1erq.png|left|200px]] | ||
{{STRUCTURE_1erq| PDB=1erq | SCENE= }} | {{STRUCTURE_1erq| PDB=1erq | SCENE= }} | ||
===X-RAY CRYSTAL STRUCTURE OF TEM-1 BETA LACTAMASE IN COMPLEX WITH A DESIGNED BORONIC ACID INHIBITOR (1R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID=== | ===X-RAY CRYSTAL STRUCTURE OF TEM-1 BETA LACTAMASE IN COMPLEX WITH A DESIGNED BORONIC ACID INHIBITOR (1R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID=== | ||
{{ABSTRACT_PUBMED_10820001}} | {{ABSTRACT_PUBMED_10820001}} | ||
==About this Structure== | ==About this Structure== | ||
[[1erq]] is a 1 chain structure of [[Beta-lactamase]] with sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1ERQ OCA]. | |||
==See Also== | |||
*[[Beta-lactamase|Beta-lactamase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:010820001</ref><references group="xtra"/> | ||
[[Category: Beta-lactamase]] | [[Category: Beta-lactamase]] | ||
[[Category: Escherichia coli]] | [[Category: Escherichia coli]] | ||
| Line 35: | Line 26: | ||
[[Category: Beta-lactamase]] | [[Category: Beta-lactamase]] | ||
[[Category: Boronate inhibitor]] | [[Category: Boronate inhibitor]] | ||
[[Category: Hydrolase]] | |||
[[Category: Structure-based design]] | [[Category: Structure-based design]] | ||
Revision as of 11:29, 27 July 2012
X-RAY CRYSTAL STRUCTURE OF TEM-1 BETA LACTAMASE IN COMPLEX WITH A DESIGNED BORONIC ACID INHIBITOR (1R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID
Template:ABSTRACT PUBMED 10820001
About this Structure
1erq is a 1 chain structure of Beta-lactamase with sequence from Escherichia coli. Full crystallographic information is available from OCA.
See Also
Reference
- Ness S, Martin R, Kindler AM, Paetzel M, Gold M, Jensen SE, Jones JB, Strynadka NC. Structure-based design guides the improved efficacy of deacylation transition state analogue inhibitors of TEM-1 beta-Lactamase(,). Biochemistry. 2000 May 9;39(18):5312-21. PMID:10820001